Precision Medicine Online’s Post

Great to see this vital work taking centre stage. Great story, and an amazing service. Early detection is key to improving outcomes. https://lnkd.in/eivSPz5t

🔬🌍 Major Advance in Kidney Cancer Diagnosis! 🌍🔬   We’re excited to share a breakthrough in kidney cancer detection developed right here in Victoria! With over 4,500 Australians diagnosed each year, Zircaix - an innovative imaging tool by Telix Pharmaceuticals Limited - is set to transform diagnosis and treatment worldwide.   Zircaix combines an antibody with a radioactive probe to target a protein produced by kidney cancer cells, allowing precise tumour detection on scans. In a multinational phase three study with 300 patients, it proved to be a game-changer, offering a non-invasive alternative to biopsies, and reducing unnecessary surgeries.   Our very own Prof. Andrew Scott played a key role in these successful clinical trials which showcased the tool’s exceptional accuracy and safety. Published in The Lancet Oncology, the findings underscore Zircaix’s potential to improve patient outcomes globally.   Congratulations to Prof. Scott and the entire team involved in this remarkable achievement! 🎉👏   🔗 Learn more in today's Herald Sun. ____________________________________   #KidneyCancer #CancerResearch #ONJCRI #Innovation #MedicalImaging #ClinicalTrials #PrecisionMedicine #GlobalImpact

This webinar provides a first view of key pharma metrics for 2023 based on data from MIDAS, MIDAS Disease and ChannelDynamics. Join us, as we assess the current state of post-pandemic recovery, and give an outlook on what lies ahead in 2024.

Excited to share this upcoming webinar that delves into the key metrics of the #pharma industry for 2023 and provides an outlook for 2024. It’s been a challenging year with numerous shifts in the #healthcare landscape, yet the market has shown resilience, growing in value by 11%. The webinar will cover a range of topics, from the evolution of #physician engagement in the #pandemic era to deep dives into #Oncology and #Immunology therapy areas. It will also touch upon the latest trends in the generics and biosimilars sectors and review the #transformational developments in the Diabetes and Obesity markets. Don’t miss out on this opportunity to refine your #strategy with the latest insights into global sales and volume trends. Register now! #PharmaIndustry #HealthcareTrends #Webinar

Ready to refine your pharma strategy for 2024? Join us for a comprehensive analysis of recent launches, physician engagement, therapy areas, #generics and #biosimilars and deep dive into the transformational developments in #oncology and #immunology, and review #diabetes and #obesity markets. Don't miss this opportunity to enhance your forecasting and strategy. Register now for next week’s webinar! https://bit.ly/48HGT4e #IQVIAMIDAS #MIDASDisease

Interesting report!

Don't miss an exclusive look into the future latest #pharmaceutical market trends. From post-pandemic recovery to emerging therapy areas, recent launches and transformational developments. Don't miss our webinar uncovering a first view of the key global sales and volume metrics and trends of 2023 and what impacts it will have on your strategy for 2024. Register now!

Check out this case report I got published.

https://lnkd.in/dtzYBCpN We like economies growing(x), ease of living improving(y) but the equation is x+y-z where z is health. A very informative video

Our recent paper on trans-synaptic tau propagation in Drosophila is in preprint